1 June 2020 - - US-based life sciences company LabCorp's (NYSE: LH) Covance drug development business has created COVID-19 Clinical Trial Connect in the US, a site designed to help people access information about how to participate in COVID-19 research, the company said.

The COVID-19 clinical trial opportunities are diverse, with sponsors recruiting patients who currently have COVID-19, those who may be now recovered, and those who may have been exposed to coronavirus.

Through the Covance COVID-19 Clinical Trial Connect site, prospective patients would be notified of studies run by Covance on behalf of a biopharmaceutical company, as well as those listed in clinicaltrials.gov.

People visiting the Covance COVID-19 Clinical Trial Connect will be invited to opt-in to register their details. This information will be used to connect people with suitable clinical studies in their area.

If a study is unavailable in their area at this time, prospective participants will have the option to be contacted when one becomes available.